Cetirizine Hydrochloride by FAMILY DOLLAR SERVICES, INC
Dosage form: tablet
Ingredients: CETIRIZINE HYDROCHLORIDE 10mg
Labeler: FAMILY DOLLAR SERVICES, INC
NDC Code: 55319-939
Cetirizine HCl, USP 10 mg
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- runny nose
- itchy, watery eyes
- itching of the nose or throat
If you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.
Liver or kidney disease. Your doctor should determine if you need a different dose.
Taking tranquilizers or sedatives.
- drowsiness may occur
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase drowsiness
- be careful when driving a motor vehicle or operating machinery
An allergic reaction to this product occurs. Seek medical help right away.
- if breast-feeding: not recommended
- if pregnant: ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
|adults and children 6 years and over||one 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms.|
|adults 65 years and over||ask a doctor|
|children under 6 years of age||ask a doctor|
|consumers with liver or kidney disease||ask a doctor|
- TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
- store between 20° to 25° C (68° to 77° F)
Corn starch, hypromellose, lactose monohydrate, magnesium stearate, polyethylene glycol, povidone, talc, titanium dioxide
COMPARE TO THE ACTIVE INGREDIENT OF ZYRTEC®*
OR YOUR MONEY BACK
Cetirizine HCl Tablets, USP 10 mg/Antihistamine
Indoor & Outdoor Allergies
• Itchy, Watery Eyes
• Runny Nose
• Itchy Throat or Nose
Original Prescription Strength
14 TABLETS 10 mg EACH
cetirizine hydrochloride tablet
|Labeler - FAMILY DOLLAR SERVICES, INC (024472631)|
|Ohm Laboratories Inc.||184769029||manufacture(55319-939)|
Medically reviewed on Jan 8, 2018